Progress And Pitfalls Ahead As UK Medtech Faces A Year Of Leaving The EU
As the UK enters the final week of its 47-year membership of the EU, UK medtech industry and commentators look ahead to the routes beyond Brexit for the UK, and a likely intense and often rocky 11 months of trade deal negotiations with EU and global partners. This article is part one of two.
You may also be interested in...
Brexit And Medtech Regulation: Sorry To Spoil The Party But Experts Say There’s A Mess Here To Clear Up
31 January 2020 is an historic day as the UK formally leaves the EU. It is an emotional day, both for those wanting to see the UK depart and those who wanted the UK to remain. But the challenges are far from over. Medtech Insight reports on some reactions from key regulatory experts.
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.
With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.